(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib

(18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) are useful imaging modalities for evaluating tumor progression and treatment responses in genetically engineered mouse models of solid human cancers, but the potential of integrated FDG-PET/CT for assessing...

Descripción completa

Detalles Bibliográficos
Autores principales: Duncan, K, Rosean, T R, Tompkins, V S, Olivier, A, Sompallae, R, Zhan, F, Tricot, G, Acevedo, M R, Ponto, L L B, Walsh, S A, Tygrett, L T, Berger, A J, Waldschmidt, T, Morse, H C, Sunderland, J J, Janz, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880444/
https://www.ncbi.nlm.nih.gov/pubmed/24292417
http://dx.doi.org/10.1038/bcj.2013.61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880444/
https://www.ncbi.nlm.nih.gov/pubmed/24292417
http://dx.doi.org/10.1038/bcj.2013.61

Ejemplares similares